Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | TACR2 | P21452 | 9/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TACR1 | P25103 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6595763 | 0.93 | LMNA (0.45) | LMNAMAPTTSHRTDP1TACR2 | |
| SCHEMBL6598099 | 0.90 | LMNA (0.49) | LMNAMAPTTSHRTDP1TACR2 | |
| SCHEMBL6593467 | 0.90 | LMNA (0.48) | LMNAMAPTTSHRTDP1TACR2 | |
| SCHEMBL6597393 | 0.90 | LMNA (0.48) | LMNAMAPTTSHRTDP1TACR2 | |
| SCHEMBL6595755 | 0.90 | MAPT (0.47) | LMNAMAPTTSHRTDP1TACR2 | |
| SCHEMBL6597238 | 0.89 | LMNA (0.46) | LMNAMAPTTSHRTDP1TACR2 | |
| SCHEMBL6594461 | 0.89 | TACR2 (0.41) | LMNAMAPTTACR2ALDH1A1TACR1 | |
| SCHEMBL6595217 | 0.88 | TACR2 (0.63) | TACR2TACR1 | |
| SCHEMBL6595639 | 0.87 | TACR2 (0.47) | TACR2 | |
| SCHEMBL6599128 | 0.87 | TACR2 (0.51) | TACR2TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888338-B1 | NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | AVENTIS PHARMA INC (US) | 2004-11-17 | — | — | EP | disclosed |